Postoperative asymptomatic severe hypertension: resuming home regimen

HTNmedium

A 56-year-old man with hypertension, type 2 diabetes, and CKD G3/A2 is evaluated after an uneventful elective open cholecystectomy. Home medications (amlodipine, lisinopril, hydrochlorothiazide, and glipizide) were all stopped on admission because he was NPO. He is tolerating clear liquids on postoperative day 2. BP is 178/110 mm Hg. Heart, lung, and abdominal examinations are unremarkable, and there is no edema. Sodium 138, potassium 4.4, total CO₂ 23 mEq/L; creatinine 1.4 mg/dL (stable); urine albumin-to-creatinine ratio 75 mg/g. What is the best next step in managing his hypertension?

  1. A.Prescribe labetalol IV
  2. B.Resume amlodipine, lisinopril, and HCTZCorrect
  3. C.Resume amlodipine
  4. D.Prescribe topical clonidine

Explanation

The next best step is to resume his home regimen of amlodipine, lisinopril, and hydrochlorothiazide. This patient has severe but asymptomatic hypertension (178/110 mm Hg) without evidence of acute target-organ damage: he has no neurologic, cardiac, or pulmonary symptoms, his creatinine is stable, and his examination is unremarkable. The most common cause of postoperative hypertension in a patient with chronic hypertension is interruption of home antihypertensive therapy, compounded by pain and anxiety. Asymptomatic severe hypertension does not require intravenous agents or rapid BP lowering; the goal is gradual reduction over hours to days with oral medications. He is tolerating oral intake, is euvolemic with stable kidney function and a normal potassium, and has no contraindication to any of his prior drugs. Lisinopril is particularly important given his albuminuric CKD (A2), and observational data in noncardiac surgery show that failure to resume ACE inhibitors or angiotensin receptor blockers within 48 hours after surgery is associated with higher 30-day mortality. Resuming the full three-drug regimen that previously controlled his BP is therefore the most effective and appropriate approach, with attention to adequate analgesia. Resuming amlodipine alone would lower BP, but monotherapy is unlikely to control a BP of 178/110 mm Hg in a patient who required three agents, and it omits the renoprotective ACE inhibitor indicated for albuminuric CKD. Transdermal clonidine is useful when a patient cannot take oral medications, but its onset takes 1 to 3 days, abrupt discontinuation later risks rebound hypertension, and it is unnecessary because he can take his oral regimen. Intravenous labetalol is appropriate for hypertensive emergencies with acute target-organ damage. Using it for asymptomatic severe hypertension risks precipitous BP reduction and organ hypoperfusion, and it does not address the cause, which is withdrawal of his usual medications.

Why each option

A.
Intravenous labetalol is reserved for hypertensive emergency with acute target-organ damage; in asymptomatic patients it risks abrupt BP reduction and hypoperfusion.
B.
Correct. Postoperative severe hypertension without target-organ injury most often reflects withdrawn home therapy; he tolerates oral intake, so restoring his full regimen, including renoprotective lisinopril, is appropriate.
C.
Amlodipine alone is unlikely to control 178/110 mm Hg in a patient previously needing three drugs, and it omits indicated ACE inhibition for albuminuria.
D.
Transdermal clonidine takes 1 to 3 days to act, risks rebound on withdrawal, and is unnecessary in a patient able to take oral medications.

Reference: Whelton PK, Hypertension 2018 (ACC/AHA guideline for high blood pressure in adults); Lee SM, Anesthesiology 2015 (withholding ARBs after surgery and 30-day mortality)

This is one of 1,100 questions in the MedBoardSA nephrology bank, with timed test mode, tutor mode, and progress tracking by topic.

Practise the full bank

More HTN questions

Browse other topics